Select Medical Dividend Overview and Recent Influential News Before Ex-Dividend Date on Aug 13, 2025
Generado por agente de IAAinvest Dividend Digest
sábado, 9 de agosto de 2025, 7:13 pm ET1 min de lectura
SEM--
Select Medical Holdings Corporation (NYSE: SEM) has announced a dividend of $0.063 per share, with an ex-dividend date set for Aug 13, 2025. This dividend amount is notably lower compared to the average of the last ten dividends, which stood at approximately $0.165 per share. The dividend announcement was made on Jul 30, 2025, and the payout is scheduled for Aug 28, 2025. The previous dividend, paid on May 29, 2025, was also $0.063 per share. The dividends are categorized as cash dividends.
Recently, Select MedicalSEM-- Holdings has experienced noteworthy developments that could impact its market performance and financial health. As of late, MizuhoMFG-- lowered its price target for Select Medical from $21.00 to $18.00, while maintaining an Outperform rating. This adjustment reflects analysts’ perspectives on the company's future profitability amidst evolving market conditions.
Over the past week, Select Medical reported mixed results for its Q2 2025 earnings, revealing that its revenue had grown by nearly 5% to $1.3 billion. Despite this revenue growth, the company's shares saw a decline of 20% following the earnings announcement on Jul 31, 2025. This drop indicates investor apprehension regarding the company's broader financial outlook.
Since the last update, Select Medical's stock has been influenced by strategic decisions and investments, including a new investment by XTX Topco Ltd. The stock opened at $11.89 on a recent Friday, with a market capitalization of $1.47 billion. Although the stock experienced a minor decrease of 0.5%, the investment highlights ongoing interest and potential for growth in the company.
In conclusion, Select Medical Holdings is navigating a complex financial landscape. The upcoming ex-dividend date on Aug 13, 2025, marks the last opportunity for investors to acquire shares to receive this dividend, with any purchase made post-ex-dividend date not qualifying for the current payout.
Recently, Select MedicalSEM-- Holdings has experienced noteworthy developments that could impact its market performance and financial health. As of late, MizuhoMFG-- lowered its price target for Select Medical from $21.00 to $18.00, while maintaining an Outperform rating. This adjustment reflects analysts’ perspectives on the company's future profitability amidst evolving market conditions.
Over the past week, Select Medical reported mixed results for its Q2 2025 earnings, revealing that its revenue had grown by nearly 5% to $1.3 billion. Despite this revenue growth, the company's shares saw a decline of 20% following the earnings announcement on Jul 31, 2025. This drop indicates investor apprehension regarding the company's broader financial outlook.
Since the last update, Select Medical's stock has been influenced by strategic decisions and investments, including a new investment by XTX Topco Ltd. The stock opened at $11.89 on a recent Friday, with a market capitalization of $1.47 billion. Although the stock experienced a minor decrease of 0.5%, the investment highlights ongoing interest and potential for growth in the company.
In conclusion, Select Medical Holdings is navigating a complex financial landscape. The upcoming ex-dividend date on Aug 13, 2025, marks the last opportunity for investors to acquire shares to receive this dividend, with any purchase made post-ex-dividend date not qualifying for the current payout.
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios